FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

37411004: Tissue plasminogen activator (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2002. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
62404015 Tissue plasminogen activator en Synonym Active Entire term case insensitive SNOMED CT core module
62405019 T-PA en Synonym Active Entire term case sensitive SNOMED CT core module
769275011 Tissue plasminogen activator (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tissue plasminogen activator Is a Substance with plasminogen activator mechanism of action false Inferred relationship Existential restriction modifier
Tissue plasminogen activator Is a Substance with hydrolase mechanism of action false Inferred relationship Existential restriction modifier
Tissue plasminogen activator Has disposition Hydrolase false Inferred relationship Existential restriction modifier
Tissue plasminogen activator Has disposition Plasminogen activator true Inferred relationship Existential restriction modifier
Tissue plasminogen activator Is a Substance with enzyme activator mechanism of action (substance) true Inferred relationship Existential restriction modifier
Tissue plasminogen activator Is a Substance with protease mechanism of action false Inferred relationship Existential restriction modifier
Tissue plasminogen activator Is a Protein true Inferred relationship Existential restriction modifier
Tissue plasminogen activator Is a Protease true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Tissue plasminogen activator-plasminogen activator inhibitor assay Has measured component False Tissue plasminogen activator Inferred relationship Existential restriction modifier
Tissue plasminogen activator assay Has measured component False Tissue plasminogen activator Inferred relationship Existential restriction modifier
Tissue plasminogen activator activity assay Has measured component False Tissue plasminogen activator Inferred relationship Existential restriction modifier
Tissue plasminogen activator antigen assay Has measured component False Tissue plasminogen activator Inferred relationship Existential restriction modifier
Tissue plasminogen activator antigen Direct substance False Tissue plasminogen activator Inferred relationship Existential restriction modifier
Tissue plasminogen activator-plasminogen activator inhibitor assay Component True Tissue plasminogen activator Inferred relationship Existential restriction modifier 2
Tissue plasminogen activator assay Component True Tissue plasminogen activator Inferred relationship Existential restriction modifier 1
Tissue plasminogen activator activity assay Component True Tissue plasminogen activator Inferred relationship Existential restriction modifier 1
Tissue plasminogen activator antigen assay Component True Tissue plasminogen activator Inferred relationship Existential restriction modifier 1
Reteplase Is a False Tissue plasminogen activator Inferred relationship Existential restriction modifier
Alteplase Is a False Tissue plasminogen activator Inferred relationship Existential restriction modifier
Tenecteplase Is a False Tissue plasminogen activator Inferred relationship Existential restriction modifier
Product containing tissue plasminogen activator Has active ingredient True Tissue plasminogen activator Inferred relationship Existential restriction modifier 1
Product containing reteplase Has active ingredient False Tissue plasminogen activator Inferred relationship Existential restriction modifier
Alteplase 50mg powder and solvent for injection solution vial Has active ingredient False Tissue plasminogen activator Inferred relationship Existential restriction modifier
Alteplase 20mg powder and solvent for injection solution vial Has active ingredient False Tissue plasminogen activator Inferred relationship Existential restriction modifier
Alteplase 10mg powder and solvent for injection solution vial Has active ingredient False Tissue plasminogen activator Inferred relationship Existential restriction modifier
Reteplase 10units powder and solvent for injection solution vial Has active ingredient False Tissue plasminogen activator Inferred relationship Existential restriction modifier
Product containing tenecteplase Has active ingredient False Tissue plasminogen activator Inferred relationship Existential restriction modifier
Product containing alteplase Has active ingredient False Tissue plasminogen activator Inferred relationship Existential restriction modifier
Tenecteplase 8000iu(40mg) powder and solvent for injection solution vial Has active ingredient False Tissue plasminogen activator Inferred relationship Existential restriction modifier
Tenecteplase 10,000iu(50mg) inj (pdr for recon)+solvent Has active ingredient False Tissue plasminogen activator Inferred relationship Existential restriction modifier
Alteplase 1mg injection solution 1mL vial Has active ingredient False Tissue plasminogen activator Inferred relationship Existential restriction modifier
Reteplase, recombinant 10unt/vial powder Has active ingredient False Tissue plasminogen activator Inferred relationship Existential restriction modifier
Alteplase 100mg powder Has active ingredient False Tissue plasminogen activator Inferred relationship Existential restriction modifier
Product containing only tissue plasminogen activator (medicinal product) Has active ingredient True Tissue plasminogen activator Inferred relationship Existential restriction modifier 1
Disorder of fibrinolysis caused by tissue plasminogen activator Causative agent True Tissue plasminogen activator Inferred relationship Existential restriction modifier 2
Intravenous injection of tissue plasminogen activator Direct substance True Tissue plasminogen activator Inferred relationship Existential restriction modifier 1
Intra-arterial injection of tissue plasminogen activator Direct substance True Tissue plasminogen activator Inferred relationship Existential restriction modifier 1
Metalyse 10,000unit powder and solvent for solution for injection vials (Boehringer Ingelheim Ltd) Has active ingredient False Tissue plasminogen activator Inferred relationship Existential restriction modifier
Rapilysin 10unit powder and solvent for solution for injection vials (Roche Products Ltd) Has active ingredient False Tissue plasminogen activator Inferred relationship Existential restriction modifier
Actilyse 10mg powder and solvent for solution for injection vials (Boehringer Ingelheim Ltd) Has active ingredient False Tissue plasminogen activator Inferred relationship Existential restriction modifier
Actilyse 20mg powder and solvent for solution for injection vials (Boehringer Ingelheim Ltd) Has active ingredient False Tissue plasminogen activator Inferred relationship Existential restriction modifier
Actilyse 50mg powder and solvent for solution for injection vials (Boehringer Ingelheim Ltd) Has active ingredient False Tissue plasminogen activator Inferred relationship Existential restriction modifier
Metalyse 8,000unit powder and solvent for solution for injection vials (Boehringer Ingelheim Ltd) Has active ingredient False Tissue plasminogen activator Inferred relationship Existential restriction modifier
Tenecteplase 10,000unit powder and solvent for solution for injection vials 1 vial Has active ingredient False Tissue plasminogen activator Inferred relationship Existential restriction modifier
Reteplase 10unit powder and solvent for solution for injection vials 2 vial Has active ingredient False Tissue plasminogen activator Inferred relationship Existential restriction modifier
Alteplase 10mg powder and solvent for solution for injection vials 1 vial Has active ingredient False Tissue plasminogen activator Inferred relationship Existential restriction modifier
Alteplase 20mg powder and solvent for solution for injection vials 1 vial Has active ingredient False Tissue plasminogen activator Inferred relationship Existential restriction modifier
Alteplase 50mg powder and solvent for solution for injection vials 1 vial Has active ingredient False Tissue plasminogen activator Inferred relationship Existential restriction modifier
Tenecteplase 8,000unit powder and solvent for solution for injection vials 1 vial Has active ingredient False Tissue plasminogen activator Inferred relationship Existential restriction modifier
Metalyse 10,000unit powder and solvent for solution for injection vials (Boehringer Ingelheim Ltd) 1 vial Has active ingredient False Tissue plasminogen activator Inferred relationship Existential restriction modifier
Rapilysin 10unit powder and solvent for solution for injection vials (Roche Products Ltd) 2 vial Has active ingredient False Tissue plasminogen activator Inferred relationship Existential restriction modifier
Actilyse 10mg powder and solvent for solution for injection vials (Boehringer Ingelheim Ltd) 1 vial Has active ingredient False Tissue plasminogen activator Inferred relationship Existential restriction modifier
Actilyse 20mg powder and solvent for solution for injection vials (Boehringer Ingelheim Ltd) 1 vial Has active ingredient False Tissue plasminogen activator Inferred relationship Existential restriction modifier
Actilyse 50mg powder and solvent for solution for injection vials (Boehringer Ingelheim Ltd) 1 vial Has active ingredient False Tissue plasminogen activator Inferred relationship Existential restriction modifier
Metalyse 8,000unit powder and solvent for solution for injection vials (Boehringer Ingelheim Ltd) 1 vial Has active ingredient False Tissue plasminogen activator Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start